Literature DB >> 1459451

Mechanism of transcriptional antirepression by GAL4-VP16.

G E Croston1, P J Laybourn, S M Paranjape, J T Kadonaga.   

Abstract

Promoter- and enhancer-binding factors appear to function by facilitating the transcription reaction as well as by counteracting chromatin-mediated repression (antirepression). We have examined the mechanism by which a hybrid activator, GAL4-VP16, is able to counteract histone H1-mediated repression by using both H1-DNA complexes and reconstituted H1-containing chromatin templates. The GAL4 DNA binding domain alone was sufficient to disrupt local H1-DNA interactions, but a transcriptional region was additionally necessary for antirepression. GAL4-VP16-mediated antirepression required an auxiliary factor, denoted as a co-antirepressor, which was partially purified from Drosophila embryos. We have found that the co-antirepressor activity was sensitive to digestion with RNase A. Moreover, total RNA from Drosophila embryos could partially substitute for the co-antirepressor fraction, which indicated that the co-antirepressor may function as a histone acceptor ("histone sink"). These findings suggest a model for gene activation in which sequence-specific transcription factors disrupt H1-DNA interactions at the promoter to facilitate transfer of H1 to a histone acceptor, which then allows access of the basal transcription factors to the DNA template.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1459451     DOI: 10.1101/gad.6.12a.2270

Source DB:  PubMed          Journal:  Genes Dev        ISSN: 0890-9369            Impact factor:   11.361


  35 in total

1.  RNA-dependent DNA binding activity of the Pur factor, potentially involved in DNA replication and gene transcription.

Authors:  Y Herault; G Chatelain; G Brun; D Michel
Journal:  Gene Expr       Date:  1995

2.  Differential effect of H1 variant overproduction on gene expression is due to differences in the central globular domain.

Authors:  D T Brown; A Gunjan; B T Alexander; D B Sittman
Journal:  Nucleic Acids Res       Date:  1997-12-15       Impact factor: 16.971

3.  Histone H1 represses estrogen receptor alpha transcriptional activity by selectively inhibiting receptor-mediated transcription initiation.

Authors:  Edwin Cheung; Alla S Zarifyan; W Lee Kraus
Journal:  Mol Cell Biol       Date:  2002-04       Impact factor: 4.272

4.  Activation of RNA polymerase II by topologically linked DNA-tracking proteins.

Authors:  M Ouhammouch; M H Sayre; J T Kadonaga; E P Geiduschek
Journal:  Proc Natl Acad Sci U S A       Date:  1997-06-24       Impact factor: 11.205

Review 5.  Power tools for gene expression and clonal analysis in Drosophila.

Authors:  Alberto del Valle Rodríguez; Dominic Didiano; Claude Desplan
Journal:  Nat Methods       Date:  2011-12-28       Impact factor: 28.547

6.  Core promoter specificities of the Sp1 and VP16 transcriptional activation domains.

Authors:  K H Emami; W W Navarre; S T Smale
Journal:  Mol Cell Biol       Date:  1995-11       Impact factor: 4.272

7.  Role of the histone amino termini in facilitated binding of a transcription factor, GAL4-AH, to nucleosome cores.

Authors:  M Vettese-Dadey; P Walter; H Chen; L J Juan; J L Workman
Journal:  Mol Cell Biol       Date:  1994-02       Impact factor: 4.272

8.  Isolation and characterization of two replication-dependent mouse H1 histone genes.

Authors:  Y Dong; A M Sirotkin; Y S Yang; D T Brown; D B Sittman; A I Skoultchi
Journal:  Nucleic Acids Res       Date:  1994-04-25       Impact factor: 16.971

9.  Transcriptional activation by herpes simplex virus type 1 VP16 in vitro and its inhibition by oligopeptides.

Authors:  T J Wu; G Monokian; D F Mark; C R Wobbe
Journal:  Mol Cell Biol       Date:  1994-05       Impact factor: 4.272

10.  Noninvasive imaging of therapeutic gene expression using a bidirectional transcriptional amplification strategy.

Authors:  Sunetra Ray; Ramasamy Paulmurugan; Manish R Patel; Byeong C Ahn; Lily Wu; Michael Carey; Sanjiv S Gambhir
Journal:  Mol Ther       Date:  2008-09-02       Impact factor: 11.454

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.